Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Friedman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
The Journal of Clinical Investigation|December 23, 2025
Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma modelsMontserrat Puigdelloses Vallcorba, Nishant Soni, Seung-Won Choi, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Molecular Cancer Research : MCR|July 1, 2024
NAPRT Silencing in FH-Deficient Renal Cell Carcinoma Confers Therapeutic Vulnerabilities via NAD+ DepletionKatelyn J Noronha, Karlie N Lucas, Sateja Paradkar, et al.
The Journal of Clinical Investigation|December 23, 2025
Mismatch repair deficiency drives malignant progression and alters the tumor immune microenvironment in glioblastoma modelsMontserrat Puigdelloses Vallcorba, Nishant Soni, Seung-Won Choi, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Collin D Heer, et al.
Molecular Cancer Therapeutics|April 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibitionAngela Kim, Prateek Bhardwaj, Shahyan Rehman, et al.
Pageof 3